IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic | HTML
Transcription Factor Inhibition: Lessons Learned and Emerging Targets: Trends in Molecular Medicine
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic | HTML
NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors | SpringerLink
NF-κB in the crosshairs: Rethinking an old riddle - ScienceDirect
Phosphorylation of NF-κB in Cancer | IntechOpen
Targeting IKKα kinase to prevent tumor progression and therapy resistance
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
The IKK NF-κB system: a treasure trove for drug development | Nature Reviews Drug Discovery
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma | Cell Death Discovery
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets | HTML
Frontiers | NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients | Immunology
Inhibitors of NF-κB signaling: 785 and counting | Oncogene
Frontiers | Pharmacological Inhibitors of the NLRP3 Inflammasome | Immunology
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
BET inhibitors in the treatment of hematologic malignancies: current i | OTT
Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability | Circulation Research
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
Summary of p38 inhibitors in clinical trials. | Download Table
Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence | The EMBO Journal